CSIMarket
 


Viveve Medical Inc   (VIVE)
Other Ticker:  
 

Cumulative Viveve Medical Inc 's Total Debt to Equity for Trailing Twelve Months Period

VIVE's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

VIVE Total Debt to Equity for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth -94.19 % -78.99 % -63.12 % 116.03 % 83.65 %
Y / Y Total Debt Growth 13.38 % 13.39 % -11.96 % -12.57 % -13.22 %
Total Debt to Equity for Trailing Twelve Months Period 0.68 0.41 0.29 0.24 0.27
Total Ranking # 2214 # 1701 # 1558 # 1406 # 1297
Seq. Equity Growth -77.56 % -48.05 % -32.59 % -26.02 % -18.91 %
Seq. Total Debt Growth 3.21 % 3.18 % 3.14 % 3.22 % 3.22 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2022
On the trailing twelve months basis Due to net new borrowings of 3.21%, Total Debt to Equity for Trailing Twelve Months Period improved to 0.68, below Viveve Medical Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 135 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Viveve Medical Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
VIVE Charts and Quotes
Total Debt to Equity VIVE in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 136
Sector # 544
S&P 500 # 3297


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
115.92 7.38 0.14
(Mar 31 2020)   (Mar 31 2017)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Medical Equipment & Supplies Industry Total Debt to Equity for Trailing Twelve Months Period
Vapotherm Inc   1.85 
Invacare Holdings Corporation  1.84 
Eargo Inc   1.74 
Cadre Holdings Inc   1.73 
Avinger Inc   1.62 
Qhslab Inc   1.45 
Novocure Limited  1.32 
3m Company  1.17 
Conmed Corporation  1.17 
Artivion Inc   1.11 
Hill rom Holdings Inc   1.10 
Nuvasive Inc  1.08 
Haemonetics Corporation  1.07 
Carlisle Companies Incorporated  1.06 
Apollo Endosurgery inc   1.05 
Motus Gi Holdings Inc   0.98 
Modular Medical Inc   0.95 
Cerus Corporation  0.87 
Dexcom Inc   0.87 
Silk Road Medical Inc   0.86 
Integra Lifesciences Holdings Corp  0.86 
Stryker Corp  0.84 
Bioventus Inc   0.81 
Neuropace Inc   0.80 
Msa Safety Incorporated  0.73 
Infusystem Holdings Inc  0.70 
Becton Dickinson And Company  0.68 
Tandem Diabetes Care Inc   0.67 
Better Therapeutics Inc   0.65 
National Vision Holdings Inc   0.63 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com